Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM study.
Zidar N, Emanuel Cotman A, Sinnige W, Benek O, Barančokova M, Zega A, Peterlin Mašič L, Tomašič T, Ilaš J, Henderson SR, Mundy JEA, Maxwell A, Stevenson CEM, Lawson DM, Jan Sterk G, Tosso R, Gutierrez L, Enriz RD, Kikelj D.
Zidar N, et al. Among authors: lawson dm.
Bioorg Med Chem. 2024 Jun 13;109:117798. doi: 10.1016/j.bmc.2024.117798. Online ahead of print.
Bioorg Med Chem. 2024.
PMID: 38906068